Kiniksa Pharmaceuticals International, plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Kiniksa Pharmaceuticals International, plc (KNSA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 359.28 thousand shares for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2024-02-28
- Kiniksa Pharmaceuticals International, plc share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 359.28K shares, a 77.94% decline from fiscal 2022.
- Kiniksa Pharmaceuticals International, plc share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 1.63M shares, a 35.71% decline from fiscal 2021.
- Kiniksa Pharmaceuticals International, plc share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 2.53M shares, a 152.50% increase from fiscal 2020.
- Kiniksa Pharmaceuticals International, plc share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2020 was 1.00M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|
| 2023-12-31 | 359.28K shares 10-K · filed 2024-02-28 |
| 2022-12-31 | 1.63M shares 10-K · filed 2023-03-02 |
| 2021-12-31 | 2.53M shares 10-K · filed 2022-02-24 |
| 2020-12-31 | 1.00M shares 10-K · filed 2021-02-25 |